Philip B. Adamson sold $9,973 of CVRX
Chief Medical Officer at CVRx, Inc.. 1,262 shares at an average of $7.90, traded Mar 2, 2026, filed Mar 16, 2026.
Score components
- +15RoleOfficer
- 0Trade size$10k at market
- 0Share of holdings soldSold 2.0% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.0%, 3m -36.7%, 6m -61.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002056191-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | AGrant or award Common Stock10b5-1 | +41,000 | $0.00 | $0 | 62,840 | Mar 16, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock10b5-1 | -1,262 | $7.90 | $9,973 | 61,578 | Mar 16, 2026 |
| Feb 27, 2026 | AGrant or award Stock Option (right to buy)derivative10b5-1 | +62,000 | $0.00 | $0 | 62,000 | Mar 16, 2026 |
Related signals
Other insiders at CVRx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | CVRx, Inc. | Brent Binkowski CHIEF OPERATING OFFICER | $3,338 1,309 shares | -4% | |
| 46Moderate | CVRXbuy CVRx, Inc. | Brent Binkowski CHIEF OPERATING OFFICER | $76k 26,223 shares | +87% | |
| 27Weak | CVRx, Inc. | Kevin Hykes PRES & CEO | $61k 7,763 shares | -3% | |
| 17Weak | CVRx, Inc. | Jared Oasheim CHIEF FINANCIAL OFFICER | $14k 1,744 shares | -2% | |
| 10Weak | CVRx, Inc. | Paul Verrastro CHIEF MKTG & STRAT OFFICER | $10k 1,284 shares | -2% | |
| 15Weak | CVRx, Inc. | Robert Allen John Chief Revenue Officer | $31k 3,964 shares | -4% | |
| 45Moderate | CVRXbuy CVRx, Inc. | Mudit K. Jain director | $298k 46,800 shares | +5% | |
| 36Weak | CVRXbuy CVRx, Inc. | Mudit K. Jain director | $2,785 600 shares | +12% | |
| 24Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $224k 22,337 shares | -1% | |
| 20Weak | CVRXsell CVRx, Inc. | Johnson & Johnson owner | $64k 6,337 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.